Sonoma Pharmaceuticals, Inc. Gains 30.65%
Tue, Sep 28, 2021 at 05:30 PM
Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ) rocketted at $6.99, representing a gain of 30.7%. On Mon, Sep 27, 2021, SNOA:NASDAQ hit a New 2-Week Intraday Low of $5.2. The stock appeared on our News Catalysts scanner on Tue, Sep 28, 2021 at 04:44 PM in the 'MISCELLANEOUS' category. From Mon, Sep 13, 2021, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Thu, Aug 19, 2021 at $13.36 with a volume of 11B+, and its share price has been moving sideways in recent weeks.
About Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ)
Sonoma Pharmaceuticals Inc is a speciality pharmaceutical company. It develops,identifies and commercialises therapies for dermatologic diseases.
Top 10 Gainers:
- CBX (Listing Market NYSE Networ (CBX:NYSE), 954.85%
- Gogo Inc. (GOGO:NASDAQ), 37.64%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 30.65%
- DATS (DATS:NASDAQ), 26.71%
- United Natural Foods, Inc. (UNFI:NYSE), 23.73%
- DBGI (DBGI:NASDAQ), 19.32%
- Planet Green Holdings Corp. (PLAG:NYSEMKT), 19.13%
- Camber Energy, Inc. (CEI:NYSEMKT), 18.38%
- Neonode Inc. (NEON:NASDAQ), 18.02%
- Schmitt Industries, Inc. (SMIT:NASDAQ), 17.78%